外泌体miRNA在甲状腺癌淋巴结转移临床诊断中的研究进展

doi:10.11904/j.issn.1002-3070.2023.05.008

Abstract

Abstract: Thyroid cancer(TC)is an inert tumor,with a high proportion of patients undergoing lymph node metastasis(LNM),and a high recurrence rate after metastasis,resulting in a poor clinical prognosis.The key to solving this problem is to find non-invasive biomarkers with high specificity.Extracellular vesicles play a crucial role in intercellular communication and epigenetic regulation by transporting genetic material.TC tumor cells can transfer genetic information to the tumor microenvironment through miRNA in exosomes,changing the surrounding microenvironment into an environment suitable for tumor growth,thereby promoting proliferation and migration of TC.This article will review the role and application prospects of extracellular miRNAs in the early diagnosis of TC metastasis in recent years,to provide a reference for exploring biomarkers of TC.

Key words: Thyroid cancer, Exosomes, Biomarkers

CLC Number:

R736.1

CAO Wenyuan, LUO Xiaoting, HE Qian. Research progress of exosomal miRNA in Clinical diagnosis of lymph node metastasis in thyroid cancer[J]. Journal of Practical Oncology, 2023, 37(5): 434-438.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2023.05.008

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2023/V37/I5/434

References

1 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
2 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
3 Asimakopoulos P,Shaha AR,Nixon IJ,et al.Management of the neck in well-differentiated thyroid cancer[J].Current Oncology Reports,2020,23(1):1.
4 Yu J,Deng Y,Liu T,et al.Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics[J].Nat Commun,2020,11(1):4807.
5 Xu SW,Mo CQ,Lin JY,et al.Loss of ID3 drives papillary thyroid cancer metastasis by targeting E47-mediated epithelial to mesenchymal transition[J].Cell Death Discov,2021,7(1):226.
6 Kim DH,Kim GJ,Kim SW,et al.Predictive value of ipsilateral central lymph node metastasis for contralateral central lymph node metastasis in patients with thyroid cancer:systematic review and meta-analysis[J].Head Neck,2021,43(10):3177-3184.
7 Feng J W,Qu Z,Ye J,et al.Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma[J].Surgery,2021,170(6):1670-1679.
8 Guo JN,Song LH,Yu PY,et al.Ultrasound elastic parameters predict central lymph node metastasis of papillary thyroid carcinoma[J].J Surg Res,2020,253:69-78.
9 李卓林,贾如雪,吴亚婷,等.肿瘤转移的分子机制及靶向干预研究新进展[J].中华细胞与干细胞杂志,2022,12(1):51-58.
10 Zhang L,Yu D.Exosomes in cancer development,metastasis,and immunity[J].Biochim Biophys Acta Rev Cancer,2019,1871(2):455-468.
11 Kandoth C,Michael D,Vandin F,et al.Mutational landscape and significance across 12 major cancer types[J].Nature,2013,502(7471):333-339.
12 W Yu,J Hurley,D Roberts,et al.Exosome-based liquid biopsies in cancer:opportunities and challenges[J].Ann Oncol,2021,32(4):466-477.
13 Kalluri R,LeBleu VS.The biology,function,and biomedical applications of exosomes[J].Science,2020,367(6478):6977.
14 Agarwal K,Saji M,Lazaroff SM,et al.Analysis of exosome release as a cellular response to MAPK pathway inhibition[J].Langmuir,2015,31(19):5440-5448.
15 Xing MZ.Molecular pathogenesis and mechanisms of thyroid cancer[J].Nat Rev Cancer,2013,13(3):184-199.
16 Sun Z,Shi K,Yang S,et al.Effect of exosomal miRNA on cancer biology and clinical applications[J].Mol Cancer,2018,17(1):147.
17 Lai EC.Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation[J].Nat Genet,2002,30(4):363-364.
18 Bracken CP,Scott HS,Goodall GJ.A network-biology perspective of microRNA function and dysfunction in cancer[J].Nat Rev Genet,2016,17(12):719-732.
19 Mehta A,Baltimore D.MicroRNAs as regulatory elements in immune system logic[J].Nat Rev Immunol,2016,16(5):279-294.
20 Silaghi CA,Lozovanu V,Silaghi H,et al.The prognostic value of microRNAs in thyroid cancers-a systematic review and meta-analysis[J].Cancers(Basel),2020,12(9):2608.
21 Stewart LA,Kuo JH.Advancements in the treatment of differentiated thyroid cancer[J].Ther Adv Endocrinol Metab,2021,12:20420188211000251.
22 Toraih EA,Elshazli RM,Trinh LN,et al.Diagnostic and prognostic performance of liquid biopsy-derived exosomal microRNAs in thyroid cancer patients:a systematic review and meta-analysis[J].Cancers(Basel),2021,13(17):4295.
23 Toraih EA,Fawzy MS,Hussein MH,et al.MicroRNA-based risk score for predic-42ting tumor progression following radioactive iodine ablation in well-differentiated thyroid cancer patients:a propensity-score matched analysis[J].Cancers(Basel),2021,13(18):4649.
24 Chan SH,Wang LH.Regulation of cancer metastasis by microRNAs[J].J Biomed Sci,2015,22(1):9.
25 Orellana EA,Kasinski AL.MicroRNAs in cancer:a historical perspective on the path from discovery to therapy[J].Cancers(Basel),2015,7(3):1388-1405.
26 Wang XZ,Hang YK,Liu JB,et al.Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2[J].J Pharmacol Sci,2016,130(2)78-84.
27 Min L,Zhu S,Chen L,et al.Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer:a comparison with plasma total miRNAs[J].J Extracell Vesicles,2019,8(1):1643670.
28 Zhu Lei,Li Jiao,Gong YL,et al.Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis[J].Mol Cancer,2019,18(1):74.
29 Peng Y,Li C,Luo DC,et al.Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma[J].Molecules,2014,19(8):11586-11599.
30 Pallante P,Visone R,Ferracin M,et al.MicroRNA deregulation in human thyroid papillary carcinomas[J].Endocrine-Related Cancer,2006,13(2):497508.
31 Zhiyun Wei,Arsen O Batagov,Sergio Schinelli,et al.Coding and noncoding landscape of extracellular RNA released by human glioma stem cells[J].Nat Commun,2017,8(1):1145.
32 Laura Santangelo,Giorgio Giurato,Carla Cicchini,et al.The RNA-binding protein syncrip is a component of the hepatocyte exosomal machinery controlling MicroRNA sorting[J].Cell Rep,2016,17(3):799-808.
33 Chen WJ,Li GP,Li ZH,et al.Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma[J].Endocrine,2022,75(3):846-855.
34 Niu MY,Li H,Li X,et al.Circulating exosomal mirnas as novel biomarkers perform superior diagnostic efficiency compared with plasma mirnas for large-artery atherosclerosis stroke[J].Front Pharmacol,2021,26(12):791644.
35 Pan Q,Zhao J,Li M,et al.Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing[J].Carcinogenesis,2020,41(1):18-24.
36 Batagov AO,Kurochkin IV.Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3'-untranslated regions[J].Biology Direct,2013,8(1):12.
37 Villarroya-Beltri C,Gutiérrez-Vázquez C,Sánchez-Cabo F,et al.Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs[J].Nat Commun,2013,4:2830.
38 Santangelo L,Giurato G,Cicchini C,et al.The RNA-binding protein syncrip is a component of the hepatocyte exosomal machinery controlling MicroRNA sorting[J].Cell Rep,2016,17(3):799-808.
39 Kim S,Choi MC,Jeong JY,et al.Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas[J].J Cancer,2019,10(9):1958-1967.
40 Yue S,Ye X,Zhou T,et al.PGRN(-/-)TAMs-de-rived exosomes inhibit breast cancer cell invasion and migration and its mechanism exploration[J].Life Sci,2021,264:118687.
41 Dai DF,Tan YW,Guo LF,et al.Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing[J].Eur J Endocrinol,2020,182(1):111-121.
43 叶卫东,邓先兆,樊友本.外泌体miRNA146b-5p促进甲状腺乳头状癌细胞迁移和侵袭[J].外科理论与实践,2019,24(4):344-348.
44 Chen WJ,Li GP,Li ZH,et al.Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma[J].Endocrine,2022,75(3):846-855.
45 Ye W,Deng X,Fan Y.Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma:a potential diagnostic and biological target for cancer therapy[J].Neoplasma,2019,66(4):516-523.
46 Jiang K,Li GP,Chen WJ,et al.Plasma exosomal miR-146b-5p and miR-222-3p are potential biomarkers for lymph node metastasis in papillary thyroid carcinomas[J].Onco Targets Ther,2020,13:1311-1319.
47 Capriglione F,Verrienti A,Celano M,et al.Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer[J].Endocrine,2022,75(1):185-193.
48 Deng X,Wu B,Xiao K,et al.MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3[J].Cell Physiol Biochem,2015,35(1):71-82.
49 Huang Y,Yu S,Cao S,et al.MicroRNA-222 promotes invasion and metastasis of papillary thyroid cancer through targeting protein phosphatase 2 regulatory subunit B alpha expression[J].Thyroid,2018,28(9):1162-1173.
50 Xiang D,Tian B,Yang T,et al.miR-222 expression is correlated with the ATA risk stratifications in papillary thyroid carcinomas[J].Medicine(Baltimore),2019,98(25):e16050.

[1]	MA Jingyu, XIANG Zhisheng, LIN Yongtian, WEN Yeying, ZHOU Yan. Epidemic characteristics and changing trends of thyroid cancer in cancer registration areas of Fujian province from 2011 to 2020 [J]. Journal of Practical Oncology, 2023, 37(4): 301-307.
[2]	GAO Zhemin, LI Xiaoxue, HUO Kai, WANG Libin, CHEN Jing, LU Wenhui. Incidence time trend and survival analysis of thyroid cancer in Cangzhou urban area from 2010 to 2019 [J]. Journal of Practical Oncology, 2023, 37(3): 195-199.
[3]	ZHANG Hui, YAN Wang, SUN Minghua. Effects of arisaema decipiens volatile oil on the malignant biological behavior of thyroid cancer cells through a miR-762/NF2 axis [J]. Journal of Practical Oncology, 2023, 37(3): 207-214.
[4]	WU Nannan, YIN Ruili, SUN Rongxin, ZHAO Dong. The diagnostic value of FAM20A in thyroid cancer was analyzed based on bioinformatics methods [J]. Journal of Practical Oncology, 2023, 37(3): 230-235.
[5]	ZHOU Xingan, SU Nite, WU Xu, DA Lintai, DELEHEI Bateer. Research progress of exosomal lncRNA in squamous cell carcinoma [J]. Journal of Practical Oncology, 2023, 37(2): 160-163.
[6]	YU Yinping, LIN Jianan, WANG Lizhong, JIANG Weihua. Effects of cancer-derived exosomes on the biological beharior of breast cancer MCF-7 cells [J]. Journal of Practical Oncology, 2023, 37(1): 26-31.
[7]	LU Jiaoyang, CHANG Jin. Research progress in biomarkers for multiple myeloma [J]. Journal of Practical Oncology, 2023, 37(1): 87-91.
[8]	LI Hao, TENG Lichen. Research status of exosomal circular RNA in prostate cancer [J]. Journal of Practical Oncology, 2023, 37(1): 92-96.
[9]	YUE Jie, YANG Qilin, SUN Xiangyu, SUN Yuming, MA Xiang, CHEN Dong, JING Guangping. Effects of exosomes derived from dental pulp stem cells on the proliferation and migration of oral squamous cell carcinoma CAL-27 and its mechanism [J]. Journal of Practical Oncology, 2022, 36(5): 398-403.
[10]	ZHAO Yaru, WU Yun. Research status of common biomarkers and corresponding targeted therapy for gastric cancer [J]. Journal of Practical Oncology, 2022, 36(5): 483-488.
[11]	ZHAO Shengwen, WU Tong. Short-term efficacy and safety of ¹³¹I combined with apatinib in the treatment of differentiated thyroid cancer with lung metastasis [J]. Journal of Practical Oncology, 2022, 36(4): 323-326.
[12]	LIU Jia, YANG Daokun, WANG Yanping, CHEN Baoxin, WANG Xinwei, SHEN Jiao. Research status of biomarkers related to the efficacy of PD-1 inhibitors in the treatment of hepatocellular carcinoma [J]. Journal of Practical Oncology, 2022, 36(4): 374-380.
[13]	CHEN Han, LUO Xiaoyong, LI Chaoping, GUO Cairu, JU Wencui, ZHAI Yangyang, SHI Xinpeng. The effect of lncRNA CASC2 on the function and angiogenesis of colorectal cancer cells [J]. Journal of Practical Oncology, 2022, 36(2): 111-118.
[14]	LIU Rui, CHEN Yang, SHI Qingping, YU Qiuli, ZHU Yunfang, WEN Hongmei. Characteristics and time trend of thyroid cancer incidence and mortality from 2012 to 2016 in cancer registration areas of Yunnan province [J]. Journal of Practical Oncology, 2021, 35(6): 489-494.
[15]	LU Junrong, WANG Huiwen, HE Dongfeng. Significance of high expression of SALL4 in clinicopathological and prognostic judgment of esophageal squamous cell carcinoma [J]. Journal of Practical Oncology, 2021, 35(5): 420-425.

Research progress of exosomal miRNA in Clinical diagnosis of lymph node metastasis in thyroid cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments